Cornell’s Research
Serves the Region and Beyond

MetaStat, Inc. CTL

R&D: Biotechnology

  • Products:
  • MetaSite Breastâ„¢
  • MenaCalcâ„¢

MetaStat, Inc. is a life sciences company aiming to develop and commercialize diagnostic products and novel therapeutics for the early and reliable prediction and treatment of systemic metastasis—cancer that spreads from a primary tumor through the bloodstream to other areas of the body. MetaStat is focused on breast, prostate, lung, and colorectal cancers, where systemic metastasis is responsible for 90% of all deaths.

Cornell Connection

The company's foundational technology is licensed from Cornell University.